Literature DB >> 9390556

Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.

W Edelmann1, K Yang, A Umar, J Heyer, K Lau, K Fan, W Liedtke, P E Cohen, M F Kane, J R Lipford, N Yu, G F Crouse, J W Pollard, T Kunkel, M Lipkin, R Kolodner, R Kucherlapati.   

Abstract

Mice carrying a null mutation in the mismatch repair gene Msh6 were generated by gene targeting. Cells that were homozygous for the mutation did not produce any detectable MSH6 protein, and extracts prepared from these cells were defective for repair of single nucleotide mismatches. Repair of 1, 2, and 4 nucleotide insertion/deletion mismatches was unaffected. Mice that were homozygous for the mutation had a reduced life span. The mice developed a spectrum of tumors, the most predominant of which were gastrointestinal tumors and B- as well as T-cell lymphomas. The tumors did not show any microsatellite instability. We conclude that MSH6 mutations, like those in some other members of the family of mismatch repair genes, lead to cancer susceptibility, and germline mutations in this gene may be associated with a cancer predisposition syndrome that does not show microsatellite instability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390556     DOI: 10.1016/s0092-8674(00)80433-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  117 in total

Review 1.  In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Authors:  J E Sale; M Bemark; G T Williams; C J Jolly; M R Ehrenstein; C Rada; C Milstein; M S Neuberger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.

Authors:  Xiaoping Wu; Connie Y Tsai; Marienida B Patam; Hong Zan; Jessica P Chen; Steve M Lipkin; Paolo Casali
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 4.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

Review 6.  Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance.

Authors:  Diane C Cabelof
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

Review 7.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

8.  Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.

Authors:  Xiao-Nan Zhao; Daman Kumari; Shikha Gupta; Di Wu; Maya Evanitsky; Wei Yang; Karen Usdin
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

Review 9.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

10.  Proteasome activator PA200 is required for normal spermatogenesis.

Authors:  Bernard Khor; Andrea L Bredemeyer; Ching-Yu Huang; Isaiah R Turnbull; Ryan Evans; Leonard B Maggi; J Michael White; Laura M Walker; Kay Carnes; Rex A Hess; Barry P Sleckman
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.